This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of phamaceuticals by gender among older adolescents age 12 to 17 from year 2010.
Search Results
These detailed tables are population illicit drug use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Illicit drugs include marijuana, cocaine, crack, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type psychotherapeutics, including pain relievers, tranquilizers, stimulants, and sedatives. Results are provided for...
This issue of the National Survey on Drug Use and Health (NSDUH) Report presents combined 2002 to 2010 data to examine substance use patterns among
This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.
This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess the average number of adolescents aged 12 to 17 using substances for the first time per day for the year as a whole and for each month of the year. Substances examined include alcohol...
This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past month alcohol use, cigarette use, marijuana use, and nonmedical use of prescription-type drugs among Hispanic youth aged 12 to 17. Results are shown for each substance by year, Hispanic subgroups, whether born in...
This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past month binge alcohol use, marijuana use, and nonmedical use of prescription-type psychotherapeutics among adolescents aged 12 to 17 by whether they had been in therapeutic foster care or traditional foster care.
This CBHSQ data review uses 2002 through 2011 National Survey on Drug Use and Health (NSDUH) data to examine recent trends in heroin initiation, including the role of nonmedical prescription pain reliever use in the heroin trend among persons aged 12 to 49. Data are presented for various age groups...
The 2008 national detailed tables for the NSDUH. The table sections are:
Highlights
1. Introduction
2. Illicit Drug Use
3. Alcohol Use
4. Tobacco Use
5. Initiation of Substance Use
6. Youth Prevention-Related Measures
7. Substance Dependence, Abuse, and Treatment
8. Mental Health
9. Discussion of Trends in Substance Use...
These are the National Detailed Tables for the 2007 NSDUH. The sections are:
Illicit Drug Use Tables - 1.1 to 1.92
Tobacco Product and Alcohol Use Tables - 2.1 to 2.84
Risk and Protective Factors Tables - 3.1 to 3.24
Incidence Tables -...
These are the 2006 NSDUH national detailed tables with the following sections:
Illicit Drug Use Tables - 1.1 to 1.92
Tobacco Product and Alcohol Use Tables - 2.1 to 2.84
Risk and Protective Factors Tables - 3.1 to 3.24
Incidence Tables -...
These are the 2005 national-level detailed tables for NSDUH.
Illicit Drug Use Tables - 1.1 to 1.132
Tobacco Product and Alcohol Use Tables - 2.1 to 2.114
Risk and Protective Factors Tables - 3.1 to 3.69
Incidence Tables - 4.1 to...
These are the 2004 national-level detailed tables for NSDUH.
Illicit Drug Use Tables - 1.1 to 1.132
Tobacco Product and Alcohol Use Tables - 2.1 to 2.114
Risk and Protective Factors Tables - 3.1 to 3.69
Incidence Tables - 4.1 to...
Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits in the Fort Lauderdale division of the Miami metropolitan area, covering 2008-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit...
Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits in the Minneapolis metropolitan area, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved...